Yep I think that wont be far away either. - Upon completion of the potential acquisition, ECQ will be re-purposed as a biotechnology company with Cynata’s technology as its chief asset
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025